In the Transthyretin Amyloidosis Outcomes Survey (THAOS) registry, over 30 different pathogenic TTR variants were reported, the most common being Val122Ile (45%), Thr60Ala (20%), and Val30Met (6%) [50]. Here, TTR is linked to amyloidosis.